TME Pharma N.V. Financial Overview
TME Pharma N.V.'s market cap is currently €6.14M. The company's EPS TTM is €-0.022; its P/E ratio is -1.34; TME Pharma N.V. is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
